Nippon India BSE Sensex Next 30 Index Fund vs NIPPON INDIA PHARMA FUND
Portfolio Overlap Analysis · Nippon vs Nippon
15.2%
Low Overlap
5 common stocks · Rank #15002 of 28,282 pairs
Common Holdings (5)
| Stock | Wt% in Nippon India BSE Sensex Next 3 | Wt% in NIPPON INDIA PHARMA | Overlap |
|---|---|---|---|
Divi's Laboratories Limited Pharmaceuticals & Biotechnology | 3.13% | 6.56% | 3.13% |
Max Healthcare Institute Limited Healthcare Services | 3.09% | 3.49% | 3.09% |
Apollo Hospitals Enterprise Limited Healthcare Services | 3.06% | 5.17% | 3.06% |
Dr. Reddy's Laboratories Limited Pharmaceuticals & Biotechnology | 3.01% | 5.81% | 3.01% |
Cipla Limited Pharmaceuticals & Biotechnology | 2.92% | 5.67% | 2.92% |
Unique to Nippon India BSE Sensex Next 3
- Shriram Finance Limited5.76%
- Hindalco Industries Limited5.11%
- Vedanta Limited4.63%
- JSW Steel Limited4.52%
- Bajaj Auto Limited4.27%
- Eicher Motors Limited4.21%
- Oil & Natural Gas Corporation Limited4.19%
- Grasim Industries Limited4.09%
- Coal India Limited3.77%
- Nestle India Limited3.53%
Unique to NIPPON INDIA PHARMA
- Sun Pharmaceutical Industries Limited13.08%
- Lupin Limited7.99%
- MedPlus Health Services Limited3.70%
- Vijaya Diagnostic Centre Limited3.49%
- Ajanta Pharma Limited3.41%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology9.1% (3)
Healthcare Services6.2% (2)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for Nippon India BSE Sensex Next 3
- vs BZ99.5% · 30 stocks
- vs SBI Nifty50 Equal Weight ETF41.0% · 20 stocks
- vs SBI Nifty50 Equal Weight Index40.9% · 20 stocks
- vs HDFC NIFTY50 Equal weight Inde40.9% · 20 stocks
- vs ICICI Prudential Nifty50 Equal38.1% · 19 stocks
More comparisons for NIPPON INDIA PHARMA
- vs HEALETF59.2% · 15 stocks
- vs NH55.9% · 14 stocks
- vs ICICI Prudential Pharma Health55.6% · 19 stocks
- vs ICICI Prudential Nifty Pharma 55.2% · 14 stocks
- vs SBI Healthcare Opportunities48.6% · 19 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.